To assess this, we examined the formation of γ-H2AX foci in response to olaparib in various cell groups, including control cells, NLRP4-knockdown cells, NLRP4-overexpressing pancreatic cancer cells, and MitoQ-treated cells (Fig. 7f–h). This evidence concerns the gene NLRP4 and familial pancreatic carcinoma.